The US pain management devices market is estimated to grow at a CAGR of more than 6% during the forecast period. The factors that are contributing to the market growth include increased R&D and high healthcare expenditure. The region has a well-developed healthcare infrastructure and a large number of biotech companies. Further, the growth of the US pain management devices market is attributed to the increasing prevalence of chronic diseases such as cancer. After the treatment of cancer, the patients experience cancer pain arises due to cancer therapy. This augments the demand for pain management devices to relieve the patients from suffering, which in turn fuel the market growth.
Visit for Global Pain Management Devices Market Report at: https://www.omrglobal.com/industry-reports/pain-management-devices-market
The US pain management devices market is segmented on the basis of type and application. Based on type, the market is segmented into an analgesic infusion pump, ablation devices, and neurostimulators. Neurostimulators held the largest share in 2018. Neurostimulators can be used for the treatment of numerous conditions, such as post-surgical pain, Parkinson’s disease, low back pain, essential tremor and migraine, and muscle weakness. On the basis of application, the market is into cancer pain, neuropathic pain, musculoskeletal pain, facial and migraine pain and trauma. Neuropathic pain held the largest share in 2018.
Moreover, the report covers the analysis of several players operating in the US pain management devices market. Some of the major players include Abbot Laboratories Inc., Baxter International Inc., Becton, Dickinson and Company, BioElectronics Corp., Boston Scientific Corp., and others. In May 2018, BioElectronics Corp. received the US FDA approval for its ActiPatch medical device for the indication- “adjunctive treatment of musculoskeletal pain. The ActiPatch was already FDA-cleared for over-the-counter treatment of pain from knee osteoarthritis and plantar fasciitis in 2017. This clearance expanded these indications to cover all musculoskeletal pain complaints.
Research Methodology
The market study of the US pain management devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for medical device companies, healthcare organizations, research institutes and academics, investing companies, potential investors, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.
Market Segmentation
1. US Pain Management Devices Market Research and Analysis by Type
2. US Pain Management Devices Market Research and Analysis by Application
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. US Pain Management Devices Market by Type
5.1.1. Analgesic Infusion Pumps
5.1.2. Ablation Devices
5.1.3. Neurostimulators
5.2. US Pain Management Devices Market by Application
5.2.1. Cancer Pain
5.2.2. Neuropathic Pain
5.2.3. Musculoskeletal Pain
5.2.4. Facial and Migraine Pain
5.2.5. Trauma
6. Company Profiles
6.1. Abbott Laboratories Inc.
6.2. Baxter International Inc.
6.3. Becton, Dickinson and Company
6.4. BioElectronics Corp.
6.5. Boston Scientific Corp.
6.6. DJO Global LLC
6.7. ICU Medical, Inc.
6.8. Pain Management Technologies, Inc.
6.9. Stryker Corp.
6.10. Theragen LLC
6.11. Nevro Corp.
1. US PAIN MANAGEMENT DEVICES MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. US PAIN MANAGEMENT DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
1. US PAIN MANAGEMENT DEVICES MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. US PAIN MANAGEMENT DEVICES MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)